Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

WeLeader Biomedical Co. Ltd. (7713) Financial Statements

WeLeader Biomedical Co. Ltd. Financial Overview

WeLeader Biomedical Co. Ltd.'s market cap is currently NT$3.21B. The company's EPS TTM is NT$5.49; its P/E ratio is 12.17; and it has a dividend yield of 5.81%. WeLeader Biomedical Co. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Mar 24Jun 23Dec 21
Income Statement
Total RevenueNT$ 1.11BNT$ 991.13MNT$ 940.70MNT$ 1.04BNT$ 841.14M
Gross ProfitNT$ 370.97MNT$ 316.32MNT$ 298.08MNT$ 291.75MNT$ 218.92M
Operating IncomeNT$ 261.22MNT$ 214.20MNT$ 197.49MNT$ 194.11MNT$ 132.28M
EBITDANT$ 384.25MNT$ 329.59MNT$ 303.04MNT$ 306.57MNT$ 252.06M
Net IncomeNT$ 208.56MNT$ 170.21MNT$ 152.28MNT$ 153.80MNT$ 105.77M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 334.71MNT$ 212.17MNT$ 104.95MNT$ 111.45MNT$ 118.71M
Total AssetsNT$ 2.45BNT$ 2.00BNT$ 1.73BNT$ 1.60BNT$ 883.09M
Total DebtNT$ 863.64MNT$ 796.77MNT$ 626.00MNT$ 701.25MNT$ 285.11M
Net DebtNT$ 625.92MNT$ 621.80MNT$ 531.30MNT$ 600.52MNT$ 173.59M
Total LiabilitiesNT$ 1.19BNT$ 1.09BNT$ 881.78MNT$ 954.19MNT$ 525.67M
Stockholders' EquityNT$ 1.26BNT$ 908.47MNT$ 845.78MNT$ 646.30MNT$ 357.41M
Cash Flow
Free Cash FlowNT$ 90.03MNT$ 104.50MNT$ 116.13MNT$ -381.38MNT$ 214.13M
Operating Cash FlowNT$ 302.77MNT$ 278.76MNT$ 231.86MNT$ 280.27MNT$ 238.03M
Investing Cash FlowNT$ -275.40MNT$ -196.65MNT$ -113.96MNT$ -665.27MNT$ -2.71M
Financing Cash FlowNT$ 35.37MNT$ -1.83MNT$ -123.94MNT$ 374.22MNT$ -225.96M

Currency in TWD

WeLeader Biomedical Co. Ltd. Earnings and Revenue History

0400M800M1.2B5 %10 %15 %20 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

WeLeader Biomedical Co. Ltd. Liabilities to Assets

01B2B3B36 %48 %60 %72 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

WeLeader Biomedical Co. Ltd. Cash Flow

-750M-500M-250M0250M500M202020212022202320242025OperatingInvestingFinancing
Cash Flow >

WeLeader Biomedical Co. Ltd. Forecast EPS vs Actual EPS

11.21.41.61.8Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >